Warning: The NCBI web site requires JavaScript to function. more...
An official website of the United States government
The .gov means it's official. Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.
The site is secure. The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.
Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Profile neighbors
LOC101928623 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors
GUCY2F - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
GEO DataSets Gene Profile neighbors Chromosome neighbors Homologene neighbors
JPH2 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
SETD3 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
NUTM1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PRR9 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ZNF536 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
KPNB1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
DIXDC1 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
PGAM5 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
EPHA4 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
FAM208A - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
CLDN18 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
LOC101928274 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
ESD - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
WDR77 - Tamoxifen effect on SRC-1-deficient endocrine-resistant breast cancer cell line LY2
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on